Drug Database
Back to search

Finland· FI-REL-REL46774

Rapibloc

A landiolol product containing landiol hydrochloride, registered in Finland by Amomed Pharma GmbH. The same ATC class is registered in 15 of our 19 countries.

ATC C07AB14

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedRapiblocATCC07AB14REGISTER NO.FI-REL-REL46774PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about landiol hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Landiolol is registered in 15 of 19 countries.

Countries holding a registration under ATC C07AB14 (landiolol), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 9 of them publish a price we can compare per daily dose
Search landiolol products by name

Landiolol · ATC C07AB14

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Landiol hydrochloride
Manufacturer
Amomed Pharma GmbH
Country
Finland (FI)
ATC code
C07AB14
ATC class
Landiolol
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under C07AB14

Landiolol, as other registers publish it.

All landiolol products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9799e6df-e1a3-4b6f-9d79-b9c7d55de28b
GET /v1/drugs/9799e6df-e1a3-4b6f-9d79-b9c7d55de28b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "infuusiokuiva-aine, liuosta varten",
  "route": "Laskimoon",
  "ddd_unit": null,
  "strength": "300 mg",
  "atc_label": "landiololi",
  "ma_number": "33001",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL46774",
  "authorised_at": "2017-09-15"
}
API referenceMCP serverPlans

See everything about landiolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console